Transcriptome Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511248574

Publication Date:

November 5, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.
The global market for Transcriptome Technology was estimated to be worth US$ 3515 million in 2023 and is forecast to a readjusted size of US$ 6850.6 million by 2030 with a CAGR of 10.0% during the forecast period 2024-2030
North American market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Transcriptome Technology was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Transcriptome Technology include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcriptome Technology, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Transcriptome Technology by region & country, by Type, and by Application.
The Transcriptome Technology market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcriptome Technology.
Market Segmentation
By Company
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm
Segment by Type:
PCR
Microarray
Sequencing
Segment by Application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Transcriptome Technology manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Transcriptome Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Transcriptome Technology in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Transcriptome Technology Product Introduction
1.2 Global Transcriptome Technology Market Size Forecast
1.3 Transcriptome Technology Market Trends & Drivers
1.3.1 Transcriptome Technology Industry Trends
1.3.2 Transcriptome Technology Market Drivers & Opportunity
1.3.3 Transcriptome Technology Market Challenges
1.3.4 Transcriptome Technology Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Transcriptome Technology Players Revenue Ranking (2023)
2.2 Global Transcriptome Technology Revenue by Company (2019-2024)
2.3 Key Companies Transcriptome Technology Manufacturing Base Distribution and Headquarters
2.4 Key Companies Transcriptome Technology Product Offered
2.5 Key Companies Time to Begin Mass Production of Transcriptome Technology
2.6 Transcriptome Technology Market Competitive Analysis
2.6.1 Transcriptome Technology Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Transcriptome Technology Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transcriptome Technology as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PCR
3.1.2 Microarray
3.1.3 Sequencing
3.2 Global Transcriptome Technology Sales Value by Type
3.2.1 Global Transcriptome Technology Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Transcriptome Technology Sales Value, by Type (2019-2030)
3.2.3 Global Transcriptome Technology Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biotechnology
4.1.2 Academic Research and Government Institutes
4.1.3 Hospitals and Diagnostic Centers
4.2 Global Transcriptome Technology Sales Value by Application
4.2.1 Global Transcriptome Technology Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Transcriptome Technology Sales Value, by Application (2019-2030)
4.2.3 Global Transcriptome Technology Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Transcriptome Technology Sales Value by Region
5.1.1 Global Transcriptome Technology Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Transcriptome Technology Sales Value by Region (2019-2024)
5.1.3 Global Transcriptome Technology Sales Value by Region (2025-2030)
5.1.4 Global Transcriptome Technology Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Transcriptome Technology Sales Value, 2019-2030
5.2.2 North America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Transcriptome Technology Sales Value, 2019-2030
5.3.2 Europe Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Transcriptome Technology Sales Value, 2019-2030
5.4.2 Asia Pacific Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Transcriptome Technology Sales Value, 2019-2030
5.5.2 South America Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Transcriptome Technology Sales Value, 2019-2030
5.6.2 Middle East & Africa Transcriptome Technology Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Transcriptome Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Transcriptome Technology Sales Value
6.3 United States
6.3.1 United States Transcriptome Technology Sales Value, 2019-2030
6.3.2 United States Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Transcriptome Technology Sales Value, 2019-2030
6.4.2 Europe Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Transcriptome Technology Sales Value, 2019-2030
6.5.2 China Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.5.3 China Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Transcriptome Technology Sales Value, 2019-2030
6.6.2 Japan Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Transcriptome Technology Sales Value, 2019-2030
6.7.2 South Korea Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Transcriptome Technology Sales Value, 2019-2030
6.8.2 Southeast Asia Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Transcriptome Technology Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Transcriptome Technology Sales Value, 2019-2030
6.9.2 India Transcriptome Technology Sales Value by Type (%), 2023 VS 2030
6.9.3 India Transcriptome Technology Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Profile
7.1.2 Thermo Fisher Scientific Main Business
7.1.3 Thermo Fisher Scientific Transcriptome Technology Products, Services and Solutions
7.1.4 Thermo Fisher Scientific Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments
7.2 Illumina
7.2.1 Illumina Profile
7.2.2 Illumina Main Business
7.2.3 Illumina Transcriptome Technology Products, Services and Solutions
7.2.4 Illumina Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.2.5 Illumina Recent Developments
7.3 QIAGEN (Exiqon)
7.3.1 QIAGEN (Exiqon) Profile
7.3.2 QIAGEN (Exiqon) Main Business
7.3.3 QIAGEN (Exiqon) Transcriptome Technology Products, Services and Solutions
7.3.4 QIAGEN (Exiqon) Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.3.5 Agilent Technologies Recent Developments
7.4 Agilent Technologies
7.4.1 Agilent Technologies Profile
7.4.2 Agilent Technologies Main Business
7.4.3 Agilent Technologies Transcriptome Technology Products, Services and Solutions
7.4.4 Agilent Technologies Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.4.5 Agilent Technologies Recent Developments
7.5 Roche
7.5.1 Roche Profile
7.5.2 Roche Main Business
7.5.3 Roche Transcriptome Technology Products, Services and Solutions
7.5.4 Roche Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.5.5 Roche Recent Developments
7.6 GE Healthcare
7.6.1 GE Healthcare Profile
7.6.2 GE Healthcare Main Business
7.6.3 GE Healthcare Transcriptome Technology Products, Services and Solutions
7.6.4 GE Healthcare Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.6.5 GE Healthcare Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Profile
7.7.2 Bio-Rad Laboratories Main Business
7.7.3 Bio-Rad Laboratories Transcriptome Technology Products, Services and Solutions
7.7.4 Bio-Rad Laboratories Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 Fluidigm
7.8.1 Fluidigm Profile
7.8.2 Fluidigm Main Business
7.8.3 Fluidigm Transcriptome Technology Products, Services and Solutions
7.8.4 Fluidigm Transcriptome Technology Revenue (US$ Million) & (2019-2024)
7.8.5 Fluidigm Recent Developments
8 Industry Chain Analysis
8.1 Transcriptome Technology Industrial Chain
8.2 Transcriptome Technology Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Transcriptome Technology Sales Model
8.5.2 Sales Channel
8.5.3 Transcriptome Technology Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂